Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

global access

NICE to oversee GP quality indicators

NICE will oversee the annual reviewing of Quality and Outcomes Framework indicators for GPs from April 1.

NICE reappoints chair, Professor Rawlins

The National Institute for Health and Clinical Excellence has reappointed Professor Sir Michael Rawlins as chairman for a further two years

Organ allocation system to be reviewed

The rules governing organ transplants for NHS patients and non-UK EU residents are to be reviewed

NICE guidance promotes benefits of NSPs

In a bid to reduce the transmission of blood-borne viruses among injecting drug users, NICE has published guidance on the optimal provision of needle and syringe programmes

Mental health funding

Health Secretary Alan Johnson and Work and Pensions Secretary James Purnell, announced that the UK government is to invest £13m to support people with depression or anxiety

New body gives nurses more freedom

Gordon Brown has appointed a new body to enable nurses and midwives to gain more control over the way they commission, manage and run their own services

Guidance on joint working

The ABPI has published new guidelines on joint working between the pharma industry and the NHS, providing greater clarity of what is allowed under the Code of Practice

Hospitals may reject top-ups

Leading hospitals in England may have to refuse patients who want to top up their care as they could be breaching NHS rules

NHS boss resigns ahead of ‘damning’ report

The chief executive of Birmingham Children's Hospital has resigned with immediate effect ahead of the publication of a report by the Healthcare Commission

Prescription prices increase

NHS prescription, dental and optical charges in England are set to increase from April 1 this year

Improved access to drugs

NICE and Lord Darzi have announced a package of measures to speed up access to new drugs and treatments for NHS patients

High Court rules against NICE in osteoporosis case

The High Court has ruled that NICE must look again at its decision not to fund the use of osteoporosis drug Protelos on the NHS

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links